811 related articles for article (PubMed ID: 15231119)
1. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
2. [Safety and immunogenicity of combined hepatitis A and hepatitis B vaccine according to 0 and 6 months schedule in healthy children].
Wang YL; Chen WY; Xu WG; Wang X; Liu Y; Wu JF; Chen JT
Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Feb; 44(2):154-6. PubMed ID: 20388338
[TBL] [Abstract][Full Text] [Related]
3. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
[TBL] [Abstract][Full Text] [Related]
6. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
[TBL] [Abstract][Full Text] [Related]
9. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
Kurugöl Z; Mutlubaş F; Ozacar T
Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.
Tsai IJ; Chang MH; Chen HL; Ni YH; Lee PI; Chiu TY; Safary A
Vaccine; 2000 Oct; 19(4-5):437-41. PubMed ID: 11027806
[TBL] [Abstract][Full Text] [Related]
11. [The immunogenicity and safety of 10 microg recombination yeast hepatitis B vaccine applied in expanded population].
Fu QP; He H; Li L; Chen HP; Zeng YX; Liu QL; Fang G; Dong CM; Guo SH; Li HG; Wang HY; He CS; Zhou SZ; Li L; Gu SN; Zhang ZF; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Oct; 43(10):903-6. PubMed ID: 20137473
[TBL] [Abstract][Full Text] [Related]
12. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
[TBL] [Abstract][Full Text] [Related]
13. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
14. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
Chlibek R; Smetana J; Bostíková V; Splino M
Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents.
Beran J; Kervyn D; Wertzova V; Hobzova L; Tichy P; Kuriyakose S; Leyssen M; Jacquet JM
Vaccine; 2010 Aug; 28(37):5993-7. PubMed ID: 20637766
[TBL] [Abstract][Full Text] [Related]
16. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
[TBL] [Abstract][Full Text] [Related]
17. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors.
Van der Wielen M; Van Damme P; Chlibek R; Smetana J; von Sonnenburg F
Vaccine; 2006 Jun; 24(26):5509-15. PubMed ID: 16725234
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
